{
    "clinical_study": {
        "@rank": "109128", 
        "arm_group": [
            {
                "arm_group_label": "crystalloid", 
                "arm_group_type": "Experimental", 
                "description": "crystalloid fluid administration, Ringer-acetat 20ml/kg under 30 minutes"
            }, 
            {
                "arm_group_label": "colloid", 
                "arm_group_type": "Experimental", 
                "description": "colloidal fluids administration, HES 6% (130/0,4)  7ml/kg under 30 minutes"
            }
        ], 
        "brief_summary": {
            "textblock": "Comparing the effects of crystalloid versus colloid fluid resuscitation in CABG patients\n      postoperatively regarding renal blood flow, glomerular filtration rate and renal oxygen\n      demand."
        }, 
        "brief_title": "Fluid Investigation Colloid vs Crystalloid Reg. Renal Hemodynamics and Function", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Renal Impairment", 
        "condition_browse": {
            "mesh_term": "Renal Insufficiency"
        }, 
        "detailed_description": {
            "textblock": "Due to blood loss and SIRS postoperative hypovolemia is a usual feature after CABG surgery.\n      Substantial controversy persists regarding the best choice of fluid to be used for\n      resuscitation in this setting regarding renal function and oxygen supply-demand matching. In\n      our study we aim to investigate differences in functional renal parameters by dividing\n      hypovolemic patients postoperatively in two groups, substituted either with crystalloid\n      fluid, Ringer-Acetat, 20 ml/kg or colloid, HES 6% (130/0,4) 10 ml/kg under 20 minutes.\n      Central and renal hemodynamics will be measured before (baseline) and after fluid\n      administration by blood sampling and thermodilution in both pulmonary artery catheter and\n      renal vein catheter. Measurement endpoints will mainly consist of central hemodynamics,\n      renal blood flow, GFR and renal oxygen extraction rate which we aim to compare between\n      groups."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  elective fast track CABG patients, postoperative\n\n        Exclusion Criteria:\n\n          -  hemodynamic instability\n\n          -  preoperative renal impairment\n\n          -  major postoperative bleeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 9, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01729364", 
            "org_study_id": "v\u00e4tskestudien"
        }, 
        "intervention": [
            {
                "arm_group_label": "crystalloid", 
                "intervention_name": "crystalloid", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Ringer Lactate", 
                    "NaCl"
                ]
            }, 
            {
                "arm_group_label": "colloid", 
                "intervention_name": "colloid", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Voluven", 
                    "Venofundin", 
                    "Tetraspan"
                ]
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "elective CABG", 
            "renal impairment", 
            "GFR", 
            "renal blood flow", 
            "colloid", 
            "crystalloid", 
            "thermodilution technique", 
            "oxygen supply demand"
        ], 
        "lastchanged_date": "December 1, 2013", 
        "location": {
            "contact": {
                "email": "jenny.skytte@vgregion.se", 
                "last_name": "Jenny Skytte, MD", 
                "phone": "0046-313429804"
            }, 
            "facility": {
                "address": {
                    "city": "G\u00f6teborg", 
                    "country": "Sweden", 
                    "state": "V\u00e4stra G\u00f6taland", 
                    "zip": "41345"
                }, 
                "name": "Sahlgrenska University Hospital/Thoracic Intensive Care"
            }, 
            "investigator": {
                "last_name": "Vitus Krumbholz, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Colloid vs Crystalloid Infusion Postoperative in CABG Patients Regarding Renal Hemodynamics and Function", 
        "overall_contact": {
            "email": "jenny.skytte@vgregion.se", 
            "last_name": "Jenny Skytte Larson, MD", 
            "phone": "0046-313429804"
        }, 
        "overall_contact_backup": {
            "email": "sven-erik.ricksten@aniv.gu.se", 
            "last_name": "Sven-Erik Ricksten, Professor", 
            "phone": "0046-313427433"
        }, 
        "overall_official": [
            {
                "affiliation": "Sahlgrenska University Hospital, Sweden", 
                "last_name": "Vitus Krumbholz, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Sahlgrenska University Hospital, Sweden", 
                "last_name": "Sven-Erik Ricksten, Professor", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Swedish Research Council", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "GFR measured by thermodilution and blood- and urine sampling baseline1 (0min), baseline2 (+30min), timepoint1 (+65min), tp2 (+85min), tp3 (+105min), tp4 (+125min)", 
            "measure": "Change from baseline and differences inbetween groups in glomerular filtration rate, measured at different timepoints", 
            "safety_issue": "No", 
            "time_frame": "125min after baseline-measures"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01729364"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sahlgrenska University Hospital, Sweden", 
            "investigator_full_name": "Vitus Krumbholz", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Sahlgrenska University Hospital, Sweden", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sahlgrenska University Hospital, Sweden", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}